MAL promoter hypermethylation as a novel prognostic marker in gastric cancer

British Journal of Cancer

Volumn 99, Issue 11, 2008, Pages 1802-1807

  Buffart, T E ^a   Overmeer, R M ^a   Steenbergen, R D M ^a   Tijssen, M ^a   Van Grieken, N C T ^a   Snijders, P J F ^a   Grabsch, H I ^b   Van De Velde, C J H ^c   Carvalho, B ^a   Meijer, G A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Gastric cancer; MAL; Prognostic marker; Promoter hypermethylation

Indexed keywords

BISULFITE; FORMALDEHYDE; PARAFFIN; PROTEIN MAL; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER SURVIVAL; CELL MATURATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE MARKER; DNA ISOLATION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; METHYLATION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH ADENOCARCINOMA; STOMACH BIOPSY; STOMACH MUCOSA; T LYMPHOCYTE;

AGED; AGED, 80 AND OVER; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; MYELIN PROTEINS; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROTEOLIPIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; ROC CURVE; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 56749169044     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604777     Document Type: Article

References (29)

1. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP (1998) Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72: 141-196
2. Beghelli S, de MG, Barbi S, Tomezzoli A, Roviello F, Di GC, Vindigni C, Bortesi L, Parisi A, Saragoni L, Scarpa A, Moore PS (2006) Microsatellite instability in gastric cancer is associated with better prognosis in only stage II cancers. Surgery 139: 347-356
3. Buffart T, Carvalho B, Hopmans E, Brehm V, Klein-Kranenbarg E, Schaaij-Visser T, Eijk P, van Grieken N, Ylstra B, van de Velde CJ, Meijer G (2007) Gastric cancers in young and elderly patients show different genomic profiles. J Pathol 211: 45-51
4. Carvalho B, Pinto M, Cirnes L, Oliveira C, Machado JC, Suriano G, Hamelin R, Carneiro F, Seruca R (2003) Concurrent hypermethylation of gene promoters is associated with a MSI-H phenotype and diploidy in gastric carcinomas. Eur J Cancer 39: 1222-1227
5. de Maat MF, van de Velde CJ, Umetani N, de HP, Putter H, van Hoesel AQ, Meijer GA, van Grieken NC, Kuppen PJ, Bilchik AJ, Tollenaar RA, Hoon DS (2007) Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer. J Clin Oncol 25: 4887-4894
6. de Wilde J, De-Castro AJ, Snijders PJ, Meijer CJ, Rosl F, Steenbergen RD (2008) Alterations in AP-1 and AP-1 regulatory genes during HPV-induced carcinogenesis. Cell Oncol 30: 77-87
7. Esteller M, Corn PG, Baylin SB, Herman JG (2001) A gene hypermethylation profile of human cancer. Cancer Res 61: 3225-3229
8. Fleisher AS, Esteller M, Wang S, Tamura G, Suzuki H, Yin J, Zou TT, Abraham JM, Kong D, Smolinski KN, Shi YQ, Rhyu MG, Powell SM, James SP, Wilson KT, Herman JG, Meltzer SJ (1999) Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res 59: 1090-1095
9. Gartner F, David L, Seruca R, Machado JC, Sobrinho-Simoes M (1996) Establishment and characterization of two cell lines derived from human diffuse gastric carcinomas xenografted in nude mice. Virchows Arch 428: 91-98
10. Hsi ED, Sup SJ, Alemany C, Tso E, Skacel M, Elson P, Alonso MA, Pohlman B (2006) MAL is expressed in a subset of Hodgkin lymphoma and identifies a population of patients with poor prognosis. Am J Clin Pathol 125: 776-782
11. Kazemi-Noureini S, Colonna-Romano S, Ziaee AA, Malboobi MA, Yazdanbod M, Setayeshgar P, Maresca B (2004) Differential gene expression between squamous cell carcinoma of esophageus and its normal epithelium; altered pattern of mal, akr1c2, and rab11a expression. World J Gastroenterol 10: 1716-1721
12. Lind GE, Ahlquist T, Kolberg M, Berg M, Eknaes M, Alonso MA, Kallioniemi A, Meling GI, Skotheim RI, Rognum TO, Thiis-Evensen E, Lothe RA (2008) Hypermethylated MAL gene - a silent marker of early colon tumorigenesis. J Transl Med 6: 13
13. Lind GE, Ahlquist T, Lothe RA (2007) DNA hypermethylation of MAL: a promising diagnostic biomarker for colorectal tumors. Gastroenterology 132: 1631-1632
14. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408
15. Machado JC, Oliveira C, Carvalho R, Soares P, Berx G, Caldas C, Seruca R, Carneiro F, Sobrinho-Simoes M (2001) E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 20: 1525-1528
16. Marazuela M, Acevedo A, Adrados M, Garcia-Lopez MA, Alonso MA (2003) Expression of MAL, an integral protein component of the machinery for raft-mediated pical transport, in human epithelia. J Histochem Cytochem 51: 665-674
17. Mimori K, Nishida K, Nakamura Y, Ieta K, Yoshikawa Y, Sasaki A, Ishii H, Alonso MA, Mori M (2007) Loss of MAL expression in precancerous lesions of the esophagus. Ann Surg Oncol 14: 1670-1677
18. Mimori K, Shiraishi T, Mashino K, Sonoda H, Yamashita K, Yoshinaga K, Masuda T, Utsunomiya T, Alonso MA, Inoue H, Mori M (2003) MAL gene expression in esophageal cancer suppresses motility, invasion and tumorigenicity and enhances apoptosis through the Fas pathway. Oncogene 22: 3463-3471
19. Mori Y, Cai K, Cheng Y, Wang S, Paun B, Hamilton JP, Jin Z, Sato F, Berki AT, Kan T, Ito T, Mantzur C, Abraham JM, Meltzer SJ (2006) A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer. Gastroenterology 131: 797-808
20. Parc Y, Gueroult S, Mourra N, Serfaty L, Flejou JF, Tiret E, Parc R (2004) Prognostic significance of microsatellite instability determined by immunohistochemical staining of MSH2 and MLH1 in sporadic T3N0M0 colon cancer. Gut 53: 371-375
21. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108
22. Puertollano R, Alonso MA (1999) MAL, an integral element of the apical sorting machinery, is an itinerant protein that cycles between the trans-Golgi network and the plasma membrane. Mol Biol Cell 10: 3435-3447
23. Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, Hamilton SR, Laurent-Puig P, Gryfe R, Shepherd LE, Tu D, Redston M, Gallinger S (2003) Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 349: 247-257
24. Steenbergen RD, Kramer D, Braakhuis BJ, Stern PL, Verheijen RH, Meijer CJ, Snijders PJ (2004) TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia. J Natl Cancer Inst 96: 294-305
25. Steenbergen RD, Walboomers JM, Meijer CJ, van der Raaij-Helmer EM, Parker JN, Chow LT, Broker TR, Snijders PJ (1996) Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: activation of telomerase and allele losses at 3p, 10p, 11q and/or 18q. Oncogene 13: 1249-1257
26. Weiss MM, Hermsen MA, Meijer GA, van Grieken NC, Baak JP, Kuipers EJ, van Diest PJ (1999) Comparative genomic hybridisation. Mol Pathol 52: 243-251
27. Weiss MM, Kuipers EJ, Postma C, Snijders AM, Siccama I, Pinkel D, Westerga J, Meuwissen SG, Albertson DG, Meijer GA (2003) Genomic profiling of gastric cancer predicts lymph node status and survival. Oncogene 22: 1872-1879
28. Wilting SM, de WJ, Meijer CJ, Berkhof J, Yi Y, van Wieringen WN, Braakhuis BJ, Meijer GA, Ylstra B, Snijders PJ, Steenbergen RD (2008) Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer. Genes Chromosomes Cancer 47(10): 890-905
29. Wisman GB, Nijhuis ER, Hoque MO, Reesink-Peters N, Koning AJ, Volders HH, Buikema HJ, Boezen HM, Hollema H, Schuuring E, Sidransky D, van der Zee AG (2006) Assessment of gene promoter hypermethylation for detection of cervical neoplasia. Int J Cancer 119: 1908-1914